Metagenomi, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +22.5% | -407.5% | – | – | |
| – | +347.8% | +142.8% | +28.5% | -1.7% | |
| – | +423.2% | +252.8% | +134.1% | -26.9% | |
| – | +50.2% | -138.0% | – | – | |
| – | +381.5% | -29.8% | -68.3% | -81.6% | |
| – | +64.4% | – | -292.8% | – | |
| – | -100.0% | – | – | – | |
| – | +500.2% | -99.6% | +8,201.7% | -100.4% | |
| – | – | -130.4% | – | – | |
| – | -26.3% | -742.8% | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.